These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 8301578
21. Evaluation of a potent inhibitor of subprimate and primate renins. Wood JM, Mah SC, Baum HP, de Gasparo M, Cumin F, Rüeger H, Nussberger J. J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974 [Abstract] [Full Text] [Related]
22. Pharmacological properties of YM-21095, a potent and highly specific renin inhibitor. Shibasaki M, Asano M, Fukunaga Y, Usui T, Ichihara M, Murakami Y, Nakano K, Fujikura T. Am J Hypertens; 1991 Dec; 4(12 Pt 1):932-8. PubMed ID: 1815649 [Abstract] [Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeys. Cook JA, Burger PJ, Michniewicz BM, Nordblom GD, Hicks GW, Kaplan C, Ryan MJ. Biopharm Drug Dispos; 1998 Apr; 19(3):185-91. PubMed ID: 9570002 [Abstract] [Full Text] [Related]
24. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide. Villamil A, Chrysant SG, Calhoun D, Schober B, Hsu H, Matrisciano-Dimichino L, Zhang J. J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194 [Abstract] [Full Text] [Related]
25. Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity. Kleinert HD, Martin D, Chekal MA, Kadam J, Luly JR, Plattner JJ, Perun TJ, Luther RR. Hypertension; 1988 Jun; 11(6 Pt 2):613-9. PubMed ID: 3292414 [Abstract] [Full Text] [Related]
26. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys. Verburg KM, Kleinert HD, Kadam JR, Chekal MA, Mento PF, Wilkes BM. Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217 [Abstract] [Full Text] [Related]
27. Acute and chronic effects of renin inhibitor GR70982 in the conscious marmoset. Gardner CJ, Twissell DJ, Charlton PA, Cherry PC. Eur J Pharmacol; 1991 Jan 17; 192(3):329-35. PubMed ID: 1905233 [Abstract] [Full Text] [Related]
28. Development of a high renin model of hypertension in the cynomolgus monkey. Panek RL, Ryan MJ, Weishaar RE, Taylor DG. Clin Exp Hypertens A; 1991 Jan 17; 13(8):1395-414. PubMed ID: 1760894 [Abstract] [Full Text] [Related]
30. Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerations. Palmer RK, Rapundalo ST, Batley BL, Barnes AE, Singh S, Ryan MJ, Taylor DG. Clin Exp Hypertens; 1993 Jul 17; 15(4):663-81. PubMed ID: 8374609 [Abstract] [Full Text] [Related]
31. A novel renal hypertensive guinea pig model for comparing different inhibitors of the renin-angiotensin system. Duan J, Jaramillo J, Jung GL, McLeod AL, Fernandes BH. J Pharmacol Toxicol Methods; 1996 Apr 17; 35(2):83-9. PubMed ID: 8729434 [Abstract] [Full Text] [Related]
32. Ro 42-5892 is a potent orally active renin inhibitor in primates. Fischli W, Clozel JP, el Amrani K, Wostl W, Neidhart W, Stadler H, Branca Q. Hypertension; 1991 Jul 17; 18(1):22-31. PubMed ID: 1830563 [Abstract] [Full Text] [Related]
33. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]. Horký K. Vnitr Lek; 2007 Apr 17; 53(4):364-70. PubMed ID: 17578167 [Abstract] [Full Text] [Related]
34. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs. Sironi G, Montagna E, Greto L, Bianchi G, Leonardi A, Testa R. Arzneimittelforschung; 1996 Feb 17; 46(2):145-52. PubMed ID: 8720303 [Abstract] [Full Text] [Related]
35. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats. Ninahuaman MF, Souccar C, Lapa AJ, Lima-Landman MT. Phytomedicine; 2007 May 17; 14(5):321-7. PubMed ID: 17433647 [Abstract] [Full Text] [Related]
36. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition. Tokita Y, Franco-Saenz R, Mulrow PJ. Am J Hypertens; 1995 Oct 17; 8(10 Pt 1):1031-9. PubMed ID: 8845072 [Abstract] [Full Text] [Related]
37. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children]. Peco-Antić A, Nastić-Mirić D, Babić D, Kostić M. Srp Arh Celok Lek; 1999 Oct 17; 127(9-10):305-11. PubMed ID: 10649899 [Abstract] [Full Text] [Related]
38. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. Anderson IK, Drew GM. Br J Pharmacol; 1997 Dec 17; 122(7):1385-94. PubMed ID: 9421286 [Abstract] [Full Text] [Related]
39. Aliskiren: an oral renin inhibitor for the treatment of hypertension. Lam S, Choy M. Cardiol Rev; 2007 Dec 17; 15(6):316-23. PubMed ID: 18090068 [Abstract] [Full Text] [Related]
40. Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat. Lee JY, Buckner SA, Brune ME, Warner RB, Winn M, De B, Zydowsky TM, Opgenorth TJ, Kerkman DJ, Debernardis JF. J Pharmacol Exp Ther; 1994 Jan 17; 268(1):427-33. PubMed ID: 8301584 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]